{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:33:10Z","timestamp":1773268390234,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.neuropharm.2013.06.027","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T05:31:50Z","timestamp":1373347910000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["FG7142, yohimbine, and \u03b2CCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta"],"prefix":"10.1016","volume":"75","author":[{"given":"Michelle","family":"Yeung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam M.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dallas","family":"Treit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clayton T.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.06.027_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2009.12.002","article-title":"Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety","volume":"65","author":"Adhikari","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pbb.2010.09.013","article-title":"Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents","volume":"97","author":"Braun","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib3","first-page":"1014","article-title":"The effect of anxiolytics and an anxiogen on the electrical activity of the frontal cortex and limbic structures of dogs with different nervous system properties","volume":"48","author":"Chilingarian","year":"1998","journal-title":"Zh. Vyssh. Nerv. Deiat. Im. I.P. Pavlova"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF02245598","article-title":"Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat","volume":"121","author":"Cole","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1037\/h0040957","article-title":"Construct validity in psychological tests","volume":"52","author":"Cronbach","year":"1955","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib6","first-page":"37","article-title":"Beta-carbolines: new insights into the clinical pharmacology of benzodiazepine receptor ligands","volume":"3","author":"Dorow","year":"1987","journal-title":"Psychopharmacol. Ser."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(83)90076-4","article-title":"Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors","volume":"2","author":"Dorow","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pharmthera.2012.08.006","article-title":"alpha2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders","volume":"136","author":"Engin","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.neuroscience.2008.09.037","article-title":"Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence","volume":"157","author":"Engin","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1527-3458.2007.00025.x","article-title":"Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects","volume":"13","author":"Evans","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/da.20642","article-title":"Current perspectives of the roles of the central norepinephrine system in anxiety and depression","volume":"27","author":"Goddard","year":"2010","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/01.HYP.5.5.772","article-title":"Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans","volume":"5","author":"Goldberg","year":"1983","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib13","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1523\/JNEUROSCI.1211-05.2005","article-title":"State-dependent alterations in hippocampal oscillations in serotonin 1A receptor-deficient mice","volume":"25","author":"Gordon","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib14","series-title":"The Neuropsychology of Anxiety: an Enquiry into the Functions of the Septo-hippocampal System","author":"Gray","year":"2000"},{"issue":"3","key":"10.1016\/j.neuropharm.2013.06.027_bib48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.neuroscience.2004.03.043","article-title":"Modulation of septo-hippocampal theta activity by GABAAreceptors: an experimental and computational approach","volume":"126","author":"Haj\u00f3s","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00504983","article-title":"Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of \u2018fear\u2019-motivated behaviour","volume":"327","author":"Handley","year":"1984","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib16","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1152\/jn.00651.2009","article-title":"Altered GABAA, slow inhibition and network oscillations in mice lacking the GABAA receptor beta3 subunit","volume":"102","author":"Hentschke","year":"2009","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A\u00a0review of the validity and variability of the elevated plus-maze as an animal model of anxiety","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0091-3057(89)90225-6","article-title":"Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites","volume":"32","author":"Johnston","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00213-002-1197-9","article-title":"5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze","volume":"164","author":"Jones","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib20","series-title":"Data Analysis for Research Design: Analysis of Variance and Multiple Regression\/Correlation Approaches","author":"Keppel","year":"1989"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib21","first-page":"99","article-title":"Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat","volume":"291","author":"Kinney","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"Luscher","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0091-3057(97)00564-9","article-title":"The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty","volume":"60","author":"Mason","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/FBP.0b013e3282ee82e3","article-title":"Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function?","volume":"18","author":"McNaughton","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0306-4522(78)90004-0","article-title":"Reticular stimulation and hippocampal theta rhythm in rats \u2013 effects of drugs","volume":"3","author":"McNaughton","year":"1978","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib26","doi-asserted-by":"crossref","first-page":"16616","DOI":"10.1523\/JNEUROSCI.1720-12.2012","article-title":"Direct alteration of a specific inhibitory circuit of the hippocampus by antidepressants","volume":"32","author":"Mendez","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X","volume":"35","author":"Millan","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(87)90117-8","article-title":"Cholinomimetics induce theta rhythm and reduce hippocampal pyramidal cell excitability","volume":"142","author":"Olpe","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib29","series-title":"The Rat Brain in Sterotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0091-3057(86)90552-6","article-title":"Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat","volume":"24","author":"Pellow","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0091-3057(95)00190-8","article-title":"Ethopharmacological analysis of the effects of putative \u2018anxiogenic\u2019 agents in the mouse elevated plus-maze","volume":"52","author":"Rodgers","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0006-8993(86)91403-4","article-title":"An analysis of cholinoceptive neurons in the hippocampal formation by direct microinfusion","volume":"362","author":"Rowntree","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib33","series-title":"Electrical Activity of the Archicortex","first-page":"11","article-title":"Type 2 theta in the guinea pig and the cat","author":"Sainsbury","year":"1985"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0014-2999(75)90268-X","article-title":"Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine","volume":"34","author":"Starke","year":"1975","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/hipo.450050405","article-title":"Dehydroepiandrosterone sulfate suppresses hippocampal recurrent inhibition and synchronizes neuronal activity to theta rhythm","volume":"5","author":"Steffensen","year":"1995","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib36","first-page":"558","article-title":"Functional modulation of cerebral gamma-aminobutyric acidA receptor\/benzodiazepine receptor\/chloride ion channel complex with ethyl beta-carboline-3-carboxylate: presence of independent binding site for ethyl beta-carboline-3-carboxylate","volume":"253","author":"Taguchi","year":"1990","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/7854_2009_17","article-title":"Animal models of anxiety and anxiolytic drug action","volume":"2","author":"Treit","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0013-4694(69)90092-3","article-title":"Hippocampal electrical activity and voluntary movement in the rat","volume":"26","author":"Vanderwolf","year":"1969","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1037\/h0076211","article-title":"Neocortical and hippocampal activation in relation to behavior \u2013 effects of atropine, eserine, phenothiazines, and amphetamine","volume":"88","author":"Vanderwolf","year":"1975","journal-title":"J.\u00a0Comp. Physiol. Psychol."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib40","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1037\/0022-3514.84.3.608","article-title":"Quantifying construct validity: two simple measures","volume":"84","author":"Westen","year":"2003","journal-title":"J.\u00a0Personal. Soc. Psychol."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib41","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.1073\/pnas.100124097","article-title":"Networks of interneurons with fast and slow gamma-aminobutyric acid type A (GABAA) kinetics provide substrate for mixed gamma-theta rhythm","volume":"97","author":"White","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib42","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1523\/JNEUROSCI.5594-05.2006","article-title":"Hippocampal slow oscillation: a novel EEG state and its coordination with ongoing neocortical activity","volume":"26","author":"Wolansky","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib43","first-page":"213","article-title":"Clonidine activates a cholinergic hippocampal theta rhythm in the rat","volume":"31","author":"Yabase","year":"1988","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1254\/jjp.76.125","article-title":"Relationship between hippocampal theta-wave frequency and emotional behaviors in rabbits produced with stresses or psychotropic drugs","volume":"76","author":"Yamamoto","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.027_bib45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/hipo.22086","article-title":"Intrahippocampal infusion of the I(h) blocker ZD7288 slows evoked theta rhythm and produces anxiolytic-like effects in the elevated plus maze","volume":"23","author":"Yeung","year":"2013","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuropharm.2011.06.011","article-title":"A\u00a0critical test of the hippocampal theta model of anxiolytic drug action","volume":"62","author":"Yeung","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.027_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0361-9230(92)90242-P","article-title":"Hippocampal mobility-related theta activity is not diminished by vigabatrin, a GABAmimetic antiepileptic drug, in normal rats","volume":"28","author":"Ylinen","year":"1992","journal-title":"Brain Res. Bull."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T10:59:31Z","timestamp":1617620371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813002967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":48,"alternative-id":["S0028390813002967"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.027","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FG7142, yohimbine, and \u03b2CCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}